Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease.
about
Influence of antidepressants on hemostasisDepression and the Link with Cardiovascular DiseaseAntidepressants and cardiovascular adverse events: A narrative reviewRole of Heart and its Diseases in the Etiology of Depression According to Avicenna's Point of View and its Comparison with Views of Classic MedicineMeditation and coronary heart disease: a review of the current clinical evidenceDepression and cardiovascular comorbidityPlatelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence?Adverse cardiovascular events in antidepressant trials involving high-risk patients: a systematic review of randomized trials.Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia.Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera.Psychosocial risk factors and retinal microvascular signs: the multi-ethnic study of atherosclerosisPathways linking late-life depression to persistent cognitive impairment and dementia.Treatment of depression in comorbid medical illness.Hemodynamic changes in depressive patientsManagement of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients.Depressive symptoms and the risk of ischemic stroke in the elderly--influence of age and sex.Cardiac risk factors in patients with diabetes mellitus and major depression.Association between depression and development of coronary artery disease: pathophysiologic and diagnostic implications.The association of co-morbid symptoms of depression and anxiety with all-cause mortality and cardiac rehospitalization in patients with heart failureDepression in vascular pathologies: the neurologist's point of view.Effects of depressive symptoms and coronary heart disease and their interactive associations on mortality in middle-aged adults: the Whitehall II cohort studySafety of antidepressant drugs in the patient with cardiac disease: a review of the literature.Depression in late life: psychiatric-medical comorbidityBroken heart: depression in cardiovascular disease.Epidemiology and treatment of depression in patients with chronic medical illness.Psychobiology of depression/distress in congestive heart failureHeart and mind: (1) relationship between cardiovascular and psychiatric conditionsRelation between psychological strain and carotid atherosclerosis in a general populationResponses of mental stress-induced myocardial ischemia to escitalopram treatment: background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trial.Depression in the elderly: new concepts and therapeutic approaches.Identify and treat depression for reduced cardiac risk and improved outcomesDepression in patients with cardiovascular disease.Negative impact of depression on outcomes in patients with coronary artery disease: mechanisms, treatment considerations, and future directions.CXCL4 Plasma Levels Are Not Associated with the Extent of Coronary Artery Disease or with Coronary Plaque Morphology.Depression and coronary heart diseaseCoronary Slow Flow is Associated with Depression and Anxiety.The 'perfect storm' and acute coronary syndrome onset: do psychosocial factors play a role?Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study--rationale, design, and methodological issues.Effect of selective serotonin reuptake inhibitors on cardiovascular morbidity and mortality.Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD).
P2860
Q24635625-81B358C8-A94E-497C-878E-1A9E55CA86BFQ26752379-397B5B3F-7A35-4E93-9B17-059678F68E64Q26771629-CE7A3C2D-9B7A-4D05-B99A-ED697C1C86F0Q28084482-C06308B4-91F2-44F0-A8BC-F8743913664DQ28086788-ABA1F0A3-6464-46D7-904C-D77BDD1906F0Q28210833-9D7967B1-C835-47D8-B29E-5B3088B0C667Q31102771-A167451A-2B3E-499C-AC5E-A11FA719B3B0Q33154720-F43E07E8-DE8D-4809-BF6E-482DB5B3992BQ33406904-52EDD461-EC15-4E54-B1BE-C2F1AA3C0A23Q33443580-44C3280C-4970-4E42-8755-84DDCAD6B3DCQ33741587-2E44938F-4C2D-4BBD-88D7-027004EE4159Q33857662-C25A2CF6-1247-48D5-9A43-FC8E7C44E6CAQ34181825-557762F5-7A0E-42A5-B6DA-78AB36A966B0Q34343277-5B72616F-74A7-4DAF-B098-E572D79B109FQ34384552-9A04AEB5-C71E-4F2E-9A20-EC1C41F63CECQ34505937-64C1155D-514A-42C0-AC64-849E849ABE62Q34733811-893F14F5-9747-419F-AD0D-72DA3CDE7530Q34772883-AD4389F7-E3A3-485C-A74A-5B7632AFFEE9Q34848435-809928D0-FF9D-44E5-B8F3-43AEC55630F0Q35122942-E6CBB861-36E0-40E0-BFC0-E3440747EF09Q35150787-F94D3C48-F736-48D2-986D-23957288D201Q35160248-8CBD0462-7A2B-4F71-87B4-8E2F4A73F49FQ35236177-20A27ECB-9CF9-4F64-A89A-2AED9292ED03Q35236309-33C99702-A42D-4A96-9F94-E8E1A71FED70Q35237231-E464ADD3-65EF-4F8C-A166-E3A7FBCE5E32Q35293910-23424899-AE4D-4E9A-8656-D53BEB21E25FQ35520767-A25A8959-12D5-40FD-9CB8-9FED5D26EDECQ35583963-3F002082-373F-4DA9-870A-02AFAF794311Q35662050-CB6A11B6-E070-48A8-889A-8CA7011D3CA7Q35907504-DA8495D0-FD4D-419B-80EF-07F8EA15A703Q36061083-98964EDA-614C-4A92-B335-0317984856EFQ36099872-4F5F7CC7-1F3E-424F-8F2C-CF52AE9B996AQ36115552-269A30F8-31DF-4F7A-A982-3E4550B67056Q36239789-8E02E2FA-C769-4D3D-9F2E-CFC15BBA34D1Q36446704-D7FDE387-24AC-4248-A068-1D6144798686Q36721397-679AC6CF-70D7-4C2C-A7F3-00D438E3A620Q36839733-44B736AC-0F62-4263-B85D-F016F9B9EF29Q36914846-5D710C3A-40E3-466A-B31F-6E49EF7F0808Q37089567-CC51576F-4EF6-4835-9BAD-5B56BF5A8E90Q37171411-70218E0D-2720-4C3F-AFC2-06033607A93B
P2860
Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Elevated platelet factor 4 and ...... s with ischemic heart disease.
@en
Elevated platelet factor 4 and ...... s with ischemic heart disease.
@nl
type
label
Elevated platelet factor 4 and ...... s with ischemic heart disease.
@en
Elevated platelet factor 4 and ...... s with ischemic heart disease.
@nl
prefLabel
Elevated platelet factor 4 and ...... s with ischemic heart disease.
@en
Elevated platelet factor 4 and ...... s with ischemic heart disease.
@nl
P2093
P1476
Elevated platelet factor 4 and ...... s with ischemic heart disease.
@en
P2093
Johnson PC
Laghrissi-Thode F
Pollock BG
P304
P356
10.1016/S0006-3223(96)00345-9
P407
P577
1997-08-01T00:00:00Z